Nigeria has commenced local production of next-generation dual-active ingredient insecticide-treated mosquito nets, in a move expected to strengthen malaria prevention and boost domestic manufacturing of essential health products….
Nigeria has commenced local production of next-generation dual-active ingredient insecticide-treated mosquito nets, in a move expected to strengthen malaria prevention and boost domestic manufacturing of essential health products.
The Federal Ministry of Health and Social Welfare said the new facility, Health Textiles Nigeria FZE, is the first in Nigeria to manufacture dual-active ingredient insecticide-treated nets.
The facility, wholly owned by Vestergaard Sàrl, will produce PermaNet® Dual, a mosquito net designed to address the growing challenge of insecticide resistance and prequalified by the World Health Organisation in 2023.
At full production capacity, the facility is expected to manufacture about 10 million nets annually and create more than 600 jobs.
About 80 employees have already been recruited and are undergoing training in manufacturing excellence, product quality, occupational health and safety, and regulatory compliance.
Coordinating Minister of Health and Social Welfare, Prof. Muhammad Ali Pate, said the development aligns with the Nigeria Health Sector Renewal Investment Initiative and its focus on unlocking the healthcare value chain through investment, local production and stronger domestic capacity.
“This investment demonstrates what is possible when government policy, private-sector investment and technology transfer come together to unlock Nigeria’s healthcare value chain.”
Pate added that local production would strengthen Nigeria’s capacity to manufacture essential health products and contribute to a more resilient health system.
The National Coordinator of the Presidential Initiative for Unlocking the Healthcare Value Chain, Dr Abdu Mukhtar, said the development demonstrates how investment, technology transfer and government policy can translate into productive capacity and skills development.
He said the training of Nigerian professionals and commencement of production represent the type of outcome the initiative seeks to replicate across other segments of the healthcare value chain.
Vestergaard Chief Executive Officer, Amar Ali, said the company was pleased to begin production in Nigeria, adding that the facility combines the company’s manufacturing expertise with Nigerian talent to produce dual-active insecticide-treated nets locally.
The establishment of Health Textiles Nigeria followed a 2024 Memorandum of Understanding between Vestergaard and the Presidential Initiative for Unlocking the Healthcare Value Chain to strengthen local production capacity for essential health products.
The development comes as Nigeria continues to bear a substantial share of the global malaria burden.
The WHO estimates that malaria caused 282 million cases and 610,000 deaths globally in 2024, with the African Region accounting for the overwhelming majority of cases and deaths.
Health Textiles Nigeria is expected to fulfil its first commercial orders in the coming months, further expanding Nigeria’s capacity to produce a critical malaria prevention commodity locally.
The Federal Ministry of Health and Social Welfare said domestic production would be supported by strong quality assurance, regulatory oversight and safety standards as the government continues to promote strategic investments, technology transfer and skills development across the healthcare value chain.
